Unknown

Dataset Information

0

Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of ca(v)2.1 calcium channels.


ABSTRACT: In this work, we studied the effects of the anticonvulsant and analgesic drug pregabalin (PGB) on excitatory postsynaptic currents (EPSCs) at principal neurons of the mouse medial nucleus of the trapezoid body and on presynaptic calcium currents at the calyx of Held. We found that the acute application of PGB reduced the amplitude of EPSCs in a dose-dependent manner with a maximal blocking effect of approximately 30%. A clinical high-concentration dose of PGB (e.g., 500 ?M) blocked Ca(v)2.1 channel-mediated currents and decreased their facilitation during a 100-Hz train, without changing their voltage-dependent activation. Furthermore, PGB also removed the inactivation of Ca(v)2.1 channels at a clinically relevant low concentration of 100 ?M. These results suggest novel modulatory mechanisms mediated by the acute administration of PGB on fast excitatory synaptic transmission and might contribute to better understanding PGB anticonvulsant/analgesic clinical effects.

SUBMITTER: Di Guilmi MN 

PROVIDER: S-EPMC3061532 | biostudies-literature | 2011 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of ca(v)2.1 calcium channels.

Di Guilmi Mariano N MN   Urbano Francisco J FJ   Inchauspe Carlota Gonzalez CG   Uchitel Osvaldo D OD  

The Journal of pharmacology and experimental therapeutics 20101222 3


In this work, we studied the effects of the anticonvulsant and analgesic drug pregabalin (PGB) on excitatory postsynaptic currents (EPSCs) at principal neurons of the mouse medial nucleus of the trapezoid body and on presynaptic calcium currents at the calyx of Held. We found that the acute application of PGB reduced the amplitude of EPSCs in a dose-dependent manner with a maximal blocking effect of approximately 30%. A clinical high-concentration dose of PGB (e.g., 500 μM) blocked Ca(v)2.1 chan  ...[more]

Similar Datasets

| S-EPMC3942855 | biostudies-literature
| S-EPMC3479455 | biostudies-literature
| S-EPMC5223599 | biostudies-literature
| S-EPMC3586721 | biostudies-literature
| S-EPMC7174704 | biostudies-literature
| S-EPMC3233975 | biostudies-literature
| S-EPMC2793404 | biostudies-literature
| S-EPMC3077595 | biostudies-literature
| S-EPMC3289374 | biostudies-other
| S-EPMC3814415 | biostudies-literature